Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a

Updated on: December 26,2023 12

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a

Updated on:December 26,2023 12

Combination drug therapy shows promise for a treatment-resistant cancer

by Johns Hopkins University School of MedicineChristine Pratilas, M.D., in the lab. Credit: Frederick W. Dubs, Johns Hopkins Pathology Photography & GraphicsA combination of two cancer drugs

Updated on: May 21,2024 4

Combination drug therapy shows promise for a treatment-resistant cancer

by Johns Hopkins University School of MedicineChristine Pratilas, M.D., in the lab. Credit: Frederick W. Dubs, Johns Hopkins Pathology Photography & GraphicsA combination of two cancer drugs

Updated on:May 21,2024 4

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on: December 18,2023 20

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on:December 18,2023 20

Benefit of risk-based breast cancer screening is still unclear

by Austrian Institute for Health Technology Assessment GmbHCredit: Unsplash/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast canc

Updated on: December 25,2023 12

Benefit of risk-based breast cancer screening is still unclear

by Austrian Institute for Health Technology Assessment GmbHCredit: Unsplash/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast canc

Updated on:December 25,2023 12

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on: December 22,2023 19

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on:December 22,2023 19

Allergy medicine may help treat lung cancer, research suggests

byThe Mount Sinai HospitalChest scans showing lung tumors in a patient with metastatic non-small cell lung cancer prior to and after receiving dupilumab with conventional immunotherapy. Credit:

Updated on: January 25,2024 20

Allergy medicine may help treat lung cancer, research suggests

byThe Mount Sinai HospitalChest scans showing lung tumors in a patient with metastatic non-small cell lung cancer prior to and after receiving dupilumab with conventional immunotherapy. Credit:

Updated on:January 25,2024 20

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis

Updated on: December 25,2023 8

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis

Updated on:December 25,2023 8

Gene interactions classify bowel tumors for personalized medicine

byeLifeFlowchart of the interaction-perturbation-based program. As an example, the background network consists of six genes and five interactions. There were three normal samples (yellow) and th

Updated on: December 25,2023 9

Gene interactions classify bowel tumors for personalized medicine

byeLifeFlowchart of the interaction-perturbation-based program. As an example, the background network consists of six genes and five interactions. There were three normal samples (yellow) and th

Updated on:December 25,2023 9

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Updated on: December 26,2023 10

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Updated on:December 26,2023 10

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on: January 04,2024 9

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on:January 04,2024 9

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023 10

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023 10

Researchers make unexpected discovery in how pancreatic cancer spreads

by Alison Satake,Mayo ClinicCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113042How cancer spreads or metastasizes is a big question for cancer researchers and patients. Mayo

Updated on: December 30,2023 15

Researchers make unexpected discovery in how pancreatic cancer spreads

by Alison Satake,Mayo ClinicCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113042How cancer spreads or metastasizes is a big question for cancer researchers and patients. Mayo

Updated on:December 30,2023 15